论文部分内容阅读
目的提高河南省、项目市(县)开展抗病毒治疗耐药性哨点监测的能力,进一步完善国家耐药性监测网络;及时掌握耐药毒株出现的情况以及影响因素,为制定合理的用药方案和减少耐药毒株出现提供科学依据;为二线抗病毒治疗的开展提供基础资料。方法按照国家H IV耐药监测方案实施,从2007年7月-2009年7月,共招募120个新纳入抗病毒治疗的艾滋病人进入监测队列,定期随访和CD4、病毒载量和基因序列监测。结果河南省先后启动两个抗病毒治疗耐药试点(唐河、宛城区)共招募病人150人。结论项目进展符合国家耐药监测方案要求。
Objectives To improve the ability of Henan Province and the project cities (counties) to carry out the anti-viral drug resistance sentinel surveillance and to further improve the national drug resistance surveillance network. To keep abreast of the emergence of drug-resistant strains and their influencing factors, in order to make rational drug use Programs and reduce the emergence of drug-resistant strains to provide a scientific basis for the implementation of second-line antiviral treatment to provide basic information. Methods According to the national H IV drug resistance monitoring program, from July 2007 to July 2009, a total of 120 AIDS patients newly recruited with antiviral therapy were enrolled into the monitoring cohort, followed up regularly and monitored for CD4, viral load and gene sequence . Results Henan Province has launched two anti-virus drug-resistant pilot (Tanghe, Wancheng District) recruited a total of 150 patients. Conclusion The progress of the project conforms to the requirements of the national drug resistance monitoring program.